New York, New York – (Newsfile Corp. – June 23, 2021) – Vincent Wong’s law firms announce that a class action lawsuit has been initiated on behalf of investors who have purchased Ocugen, Inc. (“Ocugen”) ( NASDAQ: OCGN) between February 2, 2021 and June 10, 2021.
If you have suffered a loss, contact us at the link below. There are no costs or obligations for you.
Allegations against OCGN include that the company made materially false and / or misleading statements and / or failed to disclose that: (i) the information submitted to the US Food and Drug Administration (“FDA”) was insufficient; to demonstrate emergency clearance (“EUA”), (ii) Ocugen would not file an EUA with the FDA, (iii) as a result of the foregoing were the Company’s financial statements and Defendants’ statements on the business, operations and prospects of Ocugen wrong and misleading and / or lacking a reasonable basis.
If you have suffered damage in Ocugen, you can apply until August 17, 2021 for the court to appoint you as the main plaintiff. Your ability to partake in a recovery does not require you to act as the lead plaintiff.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities disputes related to financial fraud and shareholder violations. Lawyer advertising. Previous results do not guarantee similar results.
Vincent Wong, Esq.
39 East Broadway
New York, NY 10002
Telephone number. 212.425.1140
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/88479